Rupert Hallam Department of Dermatology Royal Hallamshire Hospital Glossop Road Sheffield, England S10 2JF
To the Editor.— We were interested to read the April Archives case report by James and Odom1 describing transverse white lines in the fingernails following chemotherapy and the subsequent short report in the July Archives by Wantzin and Thomsen2 of pigmented nail bands, nail shedding, and acute paronychia following high-dose methotrexate therapy. Both sets of authors attributed the nail changes to an alteration of nail growth, and Wantzin and Thomsen postulated that this was the consequence of a direct cytotoxic action on the nail matrix and paronychium.We have long been surprised that Beau's lines and striate leukonychia, which probably both represent disturbances in nail growth of varying severity, are so seldom seen in patients undergoing systemic chemotherapy with methotrexate for psoriasis. A course of regular chemotherapy with razoxane (ICRF 159) ( ± )1,2-bis (3,5-dioxopiperazin-1-yl) propane was recently started for a 70-year-old man with severe psoriasis. This is a
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.